Clinical Trials Directory

Trials / Not Yet Recruiting

Not Yet RecruitingNCT03857737

Endoscopic Submucosal Dissection Versus Surgery in the Treatment of Early Gastric Cancer

A Study Which Compares the Long Term and Short Term Outcomes Between Endoscopic Submucosal Dissection and Surgery in the Treatment of Early Gastric Cancer

Status
Not Yet Recruiting
Phase
N/A
Study type
Interventional
Enrollment
300 (estimated)
Sponsor
Peking University Third Hospital · Academic / Other
Sex
All
Age
Healthy volunteers
Not accepted

Summary

In this study, patients who are going to undergo endoscopic submucosal dissection (ESD) or surgery for early gastric cancer will be enrolled and divided into ESD group and Surgery group according to the procedure they go through. The patients will be followed up for at least 5 years after ESD or surgery. Esophagogastroduodenoscopy (EDG) and biopsy will be performed 3 months and then 6 months after ESD or surgery. Thereafter, EDG will be performed along with biopsy and abdominal computed tomography annually up to 5 years. Patients' data such as age, sex, clinical diagnosis, achievement of en-bloc resection, pathological outcomes, complications and survival condition will be prospectively collected. Statistical methods such as Student's t-test, the chi-square test, the Kaplan-Meier method and the log-rank test will be used to compare the short term and long term outcomes between the ESD group and the surgery group.

Conditions

Interventions

TypeNameDescription
PROCEDUREendoscopic submucosal dissectionEndoscopic submucosal dissection is an endoscopic procedure which can achieve en bloc resection of GI tumor. ESD is characterized by three steps: injecting fluid into the submucosa to elevate the lesion from the muscle layer, circumferential cutting of the surrounding mucosa of the lesion, and subsequent dissection of the connective tissue of the submucosa beneath the lesion. The ESD procedure will be carried out by experienced endoscopists.
PROCEDURESurgerySurgery for EGC include Distal, proximal, or total gastrectomy, which will be performed according to the location and macroscopic tumor type by experienced surgeons.

Timeline

Start date
2019-03-01
Primary completion
2029-12-31
Completion
2029-12-31
First posted
2019-02-28
Last updated
2019-02-28

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT03857737. Inclusion in this directory is not an endorsement.